Compare Bristol-Myers Squibb Co (BMY) vs JD.Com Inc (JD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs JD.Com Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.57 (market cap $129.94B), while JD.Com Inc trades at $31.43 (market cap $44.04B). The key difference: Bristol-Myers Squibb Co is far larger — about 3× JD.Com Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | JD | |
|---|---|---|
Market Cap | $129.94B | $44.04B |
Sector | Health | Consumer Cyclical |
52-Week High | $65.89 | $36.17 |
52-Week Low | $42.60 | $25.19 |
Enterprise Value | $163.92B | $30.10B |
Dividend Yield | 3.96% | 3.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About JD.Com Inc
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →
